Effect of Huanglian Jiedu Decoction on the Expression of Monocyte Chemoattractant Protein-1 and Its Specific Receptor CCR2 mRNA in Rats with Atherosclerosis
Liu Shi-ming
Abstract
Liu Shi-ming
Abstract
Objective To investigate the effect of Huanglian Jiedu Decoction(HJD) on the expression of monocyte chemoattractant protein-1(MCP-1) and its specific receptor CCR2 mRNA in rats with atherosclerosis(AS).Methods SD rats were randomized into normal control group,model group,atorvastatin(1.8 mg·kg-1·d-1) group,and low-,moderate-and high-dosage HJD(in the dosages of 2.7,5.3 and 10.6 g·kg-1·d-1,respectively) groups.Rats except for the normal group were given high-fat diet to induce AS.In the 6th week of modeling,the rats were given the corresponding medicine according to the experimental design for 4 continuous weeks.The expression of MCP-1/CCR2 mRNA in rats aorta was detected by the method of real-time fluorescent quantitative polymerase chain reaction(RT-PCR).Results Compared with the normal control group,the expression of aortic MCP-1/CCR2 mRNA was increased in the model group(P0.05 or P0.01).The expression of aortic MCP-1/CCR2 mRNA was significantly lower in HJD groups than that in the model group(P0.05 or P0.01),in a dose-dependent manner.The expression of MCP-1 was positively correlated with CCR2 mRNA expression.Conclusion The therapeutic mechanism of HJD for AS is probably related with the down-regulation of aortic MCP-1/CCR2 mRNA.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effect of Huanglian Jiedu Decoction(HJD) on the expression of monocyte chemoattractant protein-1(MCP-1) and its specific receptor CCR2 mRNA in rats with atherosclerosis(AS).Methods SD rats were randomized into normal control group,model group,atorvastatin(1.8 mg·kg-1·d-1) group,and low-,moderate-and high-dosage HJD(in the dosages of 2.7,5.3 and 10.6 g·kg-1·d-1,respectively) groups.Rats except for the normal group were given high-fat diet to induce AS.In the 6th week of modeling,the rats were given the corresponding medicine according to the experimental design for 4 continuous weeks.The expression of MCP-1/CCR2 mRNA in rats aorta was detected by the method of real-time fluorescent quantitative polymerase chain reaction(RT-PCR).Results Compared with the normal control group,the expression of aortic MCP-1/CCR2 mRNA was increased in the model group(P0.05 or P0.01).The expression of aortic MCP-1/CCR2 mRNA was significantly lower in HJD groups than that in the model group(P0.05 or P0.01),in a dose-dependent manner.The expression of MCP-1 was positively correlated with CCR2 mRNA expression.Conclusion The therapeutic mechanism of HJD for AS is probably related with the down-regulation of aortic MCP-1/CCR2 mRNA.
Key concepts: CCR2, Monocyte, Messenger RNA, Receptor, Internal medicine, Medicine, Atorvastatin, Endocrinology